Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren's syndrome without disease modifying treatment.
Per NivedTore SaxnePierre GeborekThomas MandlLillemor SkattumMeliha C KapetanovicPublished in: BMC rheumatology (2018)
ClinicalTrials.gov Identifier: NCT02240888. Retrospectively registered 4 September, 2014.